Aflivis 40 mg/ml

Aflivis 40 mg/ml is a medicine authorised by Swissmedic under authorisation number 70062. The authorisation holder is OmniVision AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 02 February 2026 and the authorisation is limited until 01 February 2031. ATC code S01LA05 places the medicine in the group Ophthalmologicals.

  • Dispensing category B
  • Authorisation number 70062
  • ATC S01LA05
  • Biotechnological medicines
Authorisation data
Authorisation number70062
NameAflivis 40 mg/ml
Full nameAflivis 40 mg/ml, Injektionslösung in einer Fertigspritze
Authorisation holderOmniVision AG
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeS01LA05
First authorisation02 February 2026
Authorisation validity01 February 2031
Strengths
No.NameDispensing categoryAuthorisation date
1Aflivis 40 mg/ml, Injektionslösung in einer FertigspritzeB02 February 2026

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Fertigspritze(n)S01LA0511.99.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Aflivis 40 mg/ml authorised in Switzerland?

Yes. Aflivis 40 mg/ml is authorised by Swissmedic under authorisation number 70062, data as of 01 September 2026. The authorisation is limited until 01 February 2031.

Which dispensing category does Aflivis 40 mg/ml have?

Aflivis 40 mg/ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Aflivis 40 mg/ml?

The authorisation holder is OmniVision AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com